Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
85,421,304
-
Total 13F shares
-
52,292,905
-
Share change
-
+7,855,207
-
Total reported value
-
$1,524,116,576
-
Price per share
-
$29.15
-
Number of holders
-
110
-
Value change
-
+$217,206,135
-
Number of buys
-
82
-
Number of sells
-
36
Institutional Holders of Heartflow, Inc. - Common Stock (HTFL) as of Q4 2025
As of 31 Dec 2025,
Heartflow, Inc. - Common Stock (HTFL) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,292,905 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, BAILLIE GIFFORD & CO, BAMCO INC /NY/, Schusterman Interests, LLC, Capricorn Investment Group LLC, VANGUARD GROUP INC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, and BlackRock, Inc..
This page lists
110
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.